세계의 당뇨병 모니터링 기기 시장

Global Diabetes Monitoring Devices Market to Reach US$17.5 Billion by 2030

The global market for Diabetes Monitoring Devices estimated at US$12.1 Billion in the year 2024, is expected to reach US$17.5 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Devices, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Continuous Glucose Monitoring Devices segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.8% CAGR

The Diabetes Monitoring Devices market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diabetes Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Diabetes Monitoring Devices Crucial in Modern Disease Management?

Diabetes monitoring devices have become indispensable in the management of one of the world’s most prevalent chronic diseases, offering patients and healthcare providers real-time insights into blood glucose levels and enabling better decision-making in treatment plans. With diabetes affecting over 500 million people globally and projections indicating a rapid rise due to sedentary lifestyles, poor dietary habits, and aging populations, the need for precise, accessible, and continuous glucose monitoring has never been greater. These devices play a pivotal role in preventing complications such as cardiovascular disease, neuropathy, kidney failure, and vision loss by helping maintain glycemic control. Traditional devices like blood glucose meters (BGMs) remain widely used for their affordability and simplicity, but continuous glucose monitoring (CGM) systems and flash glucose monitors are gaining dominance for their ability to provide minute-by-minute updates without the need for finger pricks. The integration of Bluetooth and wireless connectivity has transformed these tools into smart devices that sync with apps, allow for cloud data storage, and offer real-time alerts, empowering patients with greater autonomy. Additionally, healthcare systems are increasingly emphasizing home-based chronic disease management, making diabetes monitoring devices essential to both individual care and broader public health outcomes.

How Is Technology Revolutionizing the Functionality of Diabetes Monitoring Devices?

Technological innovation is reshaping the diabetes monitoring landscape, driving improvements in device accuracy, usability, and integration into holistic digital health ecosystems. Continuous glucose monitors (CGMs) now offer sensor wear times of up to two weeks, with real-time tracking and predictive alerts that warn of impending hypo- or hyperglycemic events. Advances in biosensing materials and enzymatic technology have increased the precision of readings while minimizing skin irritation and calibration needs. Wearable devices are becoming smaller, more discreet, and non-invasive, with research underway for needle-free glucose monitoring using infrared spectroscopy and sweat analysis. Smartphone integration enables users to log meals, medications, and exercise alongside glucose readings, while AI-driven platforms analyze these variables to deliver personalized recommendations. Cloud-based platforms facilitate data sharing with clinicians, allowing for remote monitoring, early intervention, and reduced in-person visits-an advantage magnified during the COVID-19 pandemic. Closed-loop insulin delivery systems, often referred to as artificial pancreas technologies, are combining insulin pumps and CGMs to automate insulin delivery based on real-time glucose data. These innovations are not just enhancing convenience and comfort but are also dramatically improving outcomes for both type 1 and type 2 diabetes patients. As digital health and wearables converge, diabetes monitoring is evolving into a smart, predictive, and connected care paradigm.

Why Is Patient Empowerment and Lifestyle Integration Driving Device Adoption?

The shift toward patient-centered care and lifestyle-based disease management is significantly boosting the adoption of advanced diabetes monitoring devices. Modern patients are no longer passive recipients of care but active participants who expect tools that fit seamlessly into their daily lives while offering clear insights and actionable data. Devices that integrate easily into routine activities-like CGMs that communicate with smartwatches or fitness trackers-are gaining favor, particularly among tech-savvy users and younger demographics. The psychological impact of real-time glucose data also encourages better adherence to dietary recommendations, exercise routines, and medication schedules. For athletes, busy professionals, or caregivers managing children with diabetes, features like remote alerts and trend graphs provide peace of mind and enhanced situational control. Many of these devices now support multilingual interfaces, voice assistants, and educational features that promote understanding of disease mechanics and self-care practices. In underserved populations, simplified and affordable models are being introduced to improve access and health equity. As awareness of diabetes grows and stigma decreases, monitoring devices are increasingly viewed not as clinical tools but as everyday wellness companions. This shift in perception is fostering higher engagement and long-term commitment, critical factors in achieving successful glycemic control and reducing the overall burden of diabetes-related complications.

What Are the Key Drivers Powering Global Growth in the Diabetes Monitoring Devices Market?

The growth in the diabetes monitoring devices market is driven by a confluence of demographic, technological, policy, and behavioral factors that collectively emphasize better disease tracking and personalized care. A major driver is the escalating global prevalence of diabetes, particularly in emerging economies where urbanization, processed food consumption, and genetic predispositions are fueling a surge in new diagnoses. Simultaneously, aging populations in developed nations are contributing to increased demand for chronic disease management tools. Government initiatives and healthcare reforms are playing a supportive role by subsidizing glucose monitoring devices, expanding reimbursement coverage, and launching public awareness campaigns. The growing emphasis on preventive healthcare and remote monitoring-accelerated by the pandemic-has placed wearable glucose monitors at the center of virtual care strategies. Partnerships between tech companies and healthcare providers are also creating more integrated ecosystems, combining wearables, EHRs, and AI analytics for comprehensive diabetes management. Consumer preference for minimally invasive and user-friendly devices is shaping R&D efforts, pushing manufacturers toward innovation in design and functionality. Furthermore, strategic expansion by key industry players into Asia-Pacific, Latin America, and the Middle East is opening new growth avenues. As technology matures and global health priorities shift toward proactive care, diabetes monitoring devices are set to become foundational tools in managing this pervasive disease.

SCOPE OF STUDY:

The report analyzes the Diabetes Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices); Indication (Type-I Diabetes, Type-II Diabetes, Gestational Diabetes); End-User (Hospitals, Clinics, Home Care Settings, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Diabetes Monitoring Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Diabetes Epidemic Throws the Spotlight on Continuous Glucose Monitoring (CGM) Systems
  • Shift Toward Non-Invasive Monitoring Technologies Fuels R&D in Next-Generation Sensor Innovation
  • Growth in Wearable and App-Based Glucose Trackers Accelerates Patient Engagement and Real-Time Monitoring
  • Rising Demand for Personalized Diabetes Management Strengthens Use of Integrated CGM-Insulin Delivery Systems
  • Push Toward Value-Based Care Models Supports Use of Remote Glucose Monitoring in Chronic Disease Programs
  • Expansion of Type 2 Diabetes Screening in Emerging Markets Increases Demand for Affordable Glucometers
  • Adoption of AI and Predictive Analytics in Glucose Data Supports Real-Time Hypo/Hyperglycemia Alerts
  • Growth of Pediatric Diabetes Management Drives Need for Child-Friendly, Low-Burden Monitoring Tools
  • Increased Use of CGM in Gestational Diabetes Management Expands Clinical Application Range
  • Integration with EHR and Telehealth Services Enables Endocrinologist-Patient Collaboration
  • Consumer Preference for Discreet, Pain-Free Devices Propels Innovation in Skin-Adhesive Patch Monitors
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Diabetes Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Self-Monitoring Blood Glucose Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Continuous Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Type-I Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Type-II Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Gestational Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION